Up next

Autoplay

Kidney cancer: post-surgery sorafenib

0 Views • 06/26/23
Share
Embed
administrator
administrator
Subscribers
0

Tim Eisen, MBBChir, PhD, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, describes the rationale and methodology behind the SORCE trial (NCT00492258) and what have we learned at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay